Citigroup’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.6K Sell
2,920
-345
-11% -$2.55K ﹤0.01% 4326
2025
Q1
$28.1K Sell
3,265
-648
-17% -$5.58K ﹤0.01% 4251
2024
Q4
$140K Buy
3,913
+621
+19% +$22.2K ﹤0.01% 3813
2024
Q3
$156K Buy
3,292
+2,269
+222% +$107K ﹤0.01% 3761
2024
Q2
$51.4K Sell
1,023
-15,571
-94% -$782K ﹤0.01% 3834
2024
Q1
$1.86M Buy
16,594
+15,955
+2,497% +$1.79M ﹤0.01% 1884
2023
Q4
$37.1K Buy
639
+570
+826% +$33.1K ﹤0.01% 3929
2023
Q3
$2.2K Sell
69
-4,956
-99% -$158K ﹤0.01% 4185
2023
Q2
$413K Sell
5,025
-11,746
-70% -$966K ﹤0.01% 2864
2023
Q1
$1.72M Buy
16,771
+9,032
+117% +$928K ﹤0.01% 1626
2022
Q4
$1.13M Sell
7,739
-152
-2% -$22.3K ﹤0.01% 1921
2022
Q3
$1.33M Buy
7,891
+7,507
+1,955% +$1.27M ﹤0.01% 1898
2022
Q2
$44K Buy
384
+130
+51% +$14.9K ﹤0.01% 3911
2022
Q1
$25K Sell
254
-8,827
-97% -$869K ﹤0.01% 4308
2021
Q4
$1.41M Buy
9,081
+4,547
+100% +$707K ﹤0.01% 2234
2021
Q3
$1.07M Sell
4,534
-2,885
-39% -$680K ﹤0.01% 2346
2021
Q2
$2.52M Sell
7,419
-1,785
-19% -$606K ﹤0.01% 1930
2021
Q1
$3.72M Buy
9,204
+8,675
+1,640% +$3.51M ﹤0.01% 1538
2020
Q4
$352K Buy
529
+375
+244% +$250K ﹤0.01% 2873
2020
Q3
$72K Sell
154
-890
-85% -$416K ﹤0.01% 3298
2020
Q2
$611K Buy
1,044
+638
+157% +$373K ﹤0.01% 2433
2020
Q1
$59K Buy
406
+118
+41% +$17.1K ﹤0.01% 3664
2019
Q4
$41K Buy
288
+195
+210% +$27.8K ﹤0.01% 4092
2019
Q3
$4K Sell
93
-274
-75% -$11.8K ﹤0.01% 4840
2019
Q2
$37K Buy
367
+231
+170% +$23.3K ﹤0.01% 4286
2019
Q1
$17K Buy
136
+4
+3% +$500 ﹤0.01% 4582
2018
Q4
$14K Buy
132
+19
+17% +$2.02K ﹤0.01% 4534
2018
Q3
$28K Buy
+113
New +$28K ﹤0.01% 4384
2018
Q2
Sell
-2
Closed -$1K 5035
2018
Q1
$1K Sell
2
-51
-96% -$25.5K ﹤0.01% 4837
2017
Q4
$21K Sell
53
-699
-93% -$277K ﹤0.01% 4227
2017
Q3
$325K Buy
+752
New +$325K ﹤0.01% 2688